InvestorsHub Logo
Followers 1
Posts 153
Boards Moderated 0
Alias Born 05/24/2016

Re: gr8db8 post# 554

Monday, 01/09/2017 11:18:06 AM

Monday, January 09, 2017 11:18:06 AM

Post# of 2099
Hear u

Also like this language!


VBL's pipeline also includes the Lecinoxoids family of anti-inflammatory small molecules. In 2016, we presented results for the Phase-2-ready VB-201 drug candidate and the next-generation molecule VB-703 for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. We are exploring strategic collaborations that will advance the clinical and business potential of the Lecinoxoids, as well as pre-clinical assets from our VTS platform.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News